# FDA Inspection 730758 - Ranbaxy Inc. - June 22, 2011

Source: https://www.globalkeysolutions.net/records/fda_inspections/ranbaxy-inc/cb7c25e5-a63e-4277-b7a2-8d08a06d38a8
Source feed: FDA_Inspections

> FDA Inspection 730758 for Ranbaxy Inc. on June 22, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 730758
- Company Name: Ranbaxy Inc.
- Inspection Date: 2011-06-22
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1018135 - 2017-06-20](https://www.globalkeysolutions.net/records/fda_inspections/ranbaxy-inc/60e13819-f1b7-48c5-8008-e660560c9ad7)
- [FDA Inspection 893221 - 2014-09-04](https://www.globalkeysolutions.net/records/fda_inspections/ranbaxy-inc/ad7ddf19-2a28-4b59-b3d5-45ce2b773072)
- [FDA Inspection 730758 - 2011-06-22](https://www.globalkeysolutions.net/records/fda_inspections/ranbaxy-inc/3affa06f-034a-47b2-91ff-15f5fc9dd896)
- [FDA Inspection 612435 - 2009-09-29](https://www.globalkeysolutions.net/records/fda_inspections/ranbaxy-inc/1d956fe1-69df-485a-92b4-d64f6b413c02)

Company: https://www.globalkeysolutions.net/companies/ranbaxy-inc/83cb62ce-f991-473a-a24b-f5951066c481

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c